A detailed history of Atlantic Union Bankshares Corp transactions in Scynexis Inc stock. As of the latest transaction made, Atlantic Union Bankshares Corp holds 4,000 shares of SCYX stock, worth $3,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,000
Holding current value
$3,120
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

BUY
$0.67 - $1.07 $2,680 - $4,280
4,000 New
4,000 $2,000

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $25.5M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Atlantic Union Bankshares Corp Portfolio

Follow Atlantic Union Bankshares Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Union Bankshares Corp, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Union Bankshares Corp with notifications on news.